Parkinson’s Disease
Characteristics of Parkinson’s Disease
Parkinson’s Disease is the second most frequent neurodegenerative disorder, affecting 2-3% of the populations ages 65 and older. Traditional treatment methods are typically focused on relief from motor symptoms. Research shows overwhelming evidence that oxidative stress has a major role in neuronal degeneration. This, combined with an imbalance in antioxidant defense and repair mechanisms may lead to the loss or death of neurons in the part of the brain that plays a critical role in motor movement. Up to 40-60% of patients with Parkinson’s Disease often experience symptoms of anxiety and depression as well, which can worsen the neuromotor symptoms of Parkinson’s Disease.
- Tremors at rest
- Rigidity
- Neuronal degeneration
- Impaired and slow movement of limbs (bradykinesia)
Our Approach to Parkinson’s Disease
Hyperbaric Oxygen Therapy (HBOT)
Hyperbaric Oxygen Therapy decreases inflammation, oxygenates the entire body, stimulates the growth of new healthy blood vessels, and releases stem cells, up to 800% more after 20 sessions! Research suggests that HBOT can improve neurological outcomes by increasing enzymes in the body that protect cells and prevents neuronal damage. It has also been shown to decrease depression, anxiety, and tremors in patients with Parkinson’s Disease.
QEEG & Neurofeedback Therapy (NFB)
A Quantitative EEG shows us electrical activity of the brain. We will be able to see if inflammation is present, if there are any areas of hyper- or hypoactivity, and any areas of disconnect. Using this information, we approach Parkinson’s Disease with an intensive NFB program of two thirty-minute sessions per day for ten days, focusing on the area(s) of the brain most affected, those that affect motor function, sensory, and/or emotional regulation.
Video Testimonial
How we can help
Related Research
- Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system (clinexprheumatol.org)
- Hyperbaric oxygen treatment for Parkinson’s disease with severe depression and anxiety – PMC (nih.gov)
- (PDF) Reduced intravenous glutathione in the treatment of early Parkinson’s disease (researchgate.net)
Our Approach to Parkinson’s Disease
Hyperbaric Oxygen Therapy (HBOT)
Hyperbaric Oxygen Therapy decreases inflammation, oxygenates the entire body, stimulates the growth of new healthy blood vessels, and releases stem cells, up to 800% more after 20 sessions! Research suggests that HBOT can improve neurological outcomes by increasing enzymes in the body that protect cells and prevents neuronal damage. It has also been shown to decrease depression, anxiety, and tremors in patients with Parkinson’s Disease.
QEEG & Neurofeedback Therapy (NFB)
A Quantitative EEG shows us electrical activity of the brain. We will be able to see if inflammation is present, if there are any areas of hyper- or hypoactivity, and any areas of disconnect. Using this information, we approach Parkinson’s Disease with an intensive NFB program of two thirty-minute sessions per day for ten days, focusing on the area(s) of the brain most affected, those that affect motor function, sensory, and/or emotional regulation.